Cypress Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Hold
2,011
0.78% 42
2026
Q1
$988K Buy
2,011
+41
+2% +$22.3K 0.75% 41
2025
Q4
$1.14M Hold
1,970
0.84% 37
2025
Q3
$955K Hold
1,970
0.71% 44
2025
Q2
$799K Buy
1,970
+1,333
+209% +$557K 0.62% 46
2025
Q1
$317K Buy
637
+150
+31% +$81.2K 0.29% 54
2024
Q4
$253K Buy
+487
New +$268K 0.23% 57

Other funds holding TMO

Cypress Advisory Group's TMO Position: Q2 2026 in Review

Cypress Advisory Group held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 2,011 shares worth $1.01M. The position accounts for 0.78% of the portfolio, ranked #42.

Cypress Advisory Group first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.14M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cypress Advisory Group held 2,011 shares of Thermo Fisher Scientific worth $1.01M as of Q2 2026.
  • Cypress Advisory Group left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.78% of Cypress Advisory Group's portfolio in Q2 2026, its #42 holding.
  • Cypress Advisory Group first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Cypress Advisory Group's Thermo Fisher Scientific position peaked at $1.14M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cypress Advisory Group's 13F filing for Q2 2026, filed 17 Jul 2026.